Literature DB >> 11778125

Premedication, preparation, and surveillance.

G D Bell1.   

Abstract

The vigorous debate over whom to sedate, when to sedate, and how to sedate shows no sign of running out of steam. There is a general consensus that patients should be more involved in the decision-making process for the sedation "menu". A move away from the take-it-or-leave-it attitude of all or nothing to an "à la carte" choice is to be encouraged. A new textbook and several further guidelines have appeared. The particular problems associated with sedating the elderly are briefly presented. The pros and cons of using local pharyngeal anaesthesia are discussed. Enthusiasm for the use of intravenous propofol is gathering momentum, despite continuing worries about its safety in the hands of the nonanaesthetist. For many endoscopists, the combination of a benzodiazepine plus (or minus) an opioid with which they are most familiar is still the best compromise in terms of efficacy, cost, and safety. Fatal drug-induced cardiopulmonary complications continue to occur, despite a general trend toward using smaller doses of sedation than we did 5 - 10 years ago. Monitoring techniques that are at present considered as research tools may one day become commonplace. These include: the use of an electroencephalography parameter known as bispectral analysis; transcutaneous CO(2) measurement; and a modified continuous capnographic waveform trace to monitor ventilatory effort. Bispectral analysis may be of use in monitoring central nervous system depression and helping to distinguish between conscious sedation and deep sedation. If the measurement of CO(2) levels, either transcutaneously or in breath samples, was as easy and inexpensive as measuring SpO(2) with a pulse oximeter, then undoubtedly such technology would enhance the early detection of sedative-induced hypoventilation and apnoea. Further evidence regarding droperidol's possible role in conscious sedation is presented. Pain during colonoscopy remains a problem, and the possible role for intraluminal injection of peppermint oil, as well as the value of variable-stiffness colonoscopes, in reducing the need for intravenous sedation is discussed. Case reports of hyponatraemic encephalopathy and hypocalcaemic tetany as complications of oral bowel preparation are presented, as is the challenge associated with adequate bowel preparation in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11778125     DOI: 10.1055/s-2002-19389

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  16 in total

1.  The comparison of dexmedetomidine and midazolam used for sedation of patients during upper endoscopy: A prospective, randomized study.

Authors:  Yavuz Demiraran; Esin Korkut; Ali Tamer; Ilknur Yorulmaz; Buket Kocaman; Gulbin Sezen; Yusuf Akcan
Journal:  Can J Gastroenterol       Date:  2007-01       Impact factor: 3.522

2.  Effect of music on procedure time and sedation during colonoscopy: a meta-analysis.

Authors:  Wilson W S Tam; Eliza L Y Wong; Sheila F Twinn
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

3.  Posterior lingual lidocaine: a novel method to improve tolerance in upper gastrointestinal endoscopy.

Authors:  Assaad M Soweid; Shadi R Yaghi; Faek R Jamali; Abdallah A Kobeissy; Michella E Mallat; Rola Hussein; Chakib M Ayoub
Journal:  World J Gastroenterol       Date:  2011-12-21       Impact factor: 5.742

4.  Unsedated ultrathin upper endoscopy is better than conventional endoscopy in routine outpatient gastroenterology practice: a randomized trial.

Authors:  Lucio Trevisani; Viviana Cifalà; Sergio Sartori; Giuseppe Gilli; Giancarlo Matarese; Vincenzo Abbasciano
Journal:  World J Gastroenterol       Date:  2007-02-14       Impact factor: 5.742

5.  Listening to Turkish classical music decreases patients' anxiety, pain, dissatisfaction and the dose of sedative and analgesic drugs during colonoscopy: a prospective randomized controlled trial.

Authors:  Nimet Ovayolu; Ozlem Ucan; Seda Pehlivan; Yavuz Pehlivan; Hakan Buyukhatipoglu; M-Cemil Savas; Murat-T Gulsen
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

6.  Upper gastrointestinal endoscopy: are preparatory interventions or conscious sedation effective? A randomized trial.

Authors:  Lucio Trevisani; Sergio Sartori; Piergiorgio Gaudenzi; Giuseppe Gilli; Giancarlo Matarese; Sergio Gullini; Vincenzo Abbasciano
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

7.  Dexmedetomidine versus midazolam for sedation during endoscopy: A meta-analysis.

Authors:  Fan Zhang; Hao-Rui Sun; Ze-Bing Zheng; Ren Liao; Jin Liu
Journal:  Exp Ther Med       Date:  2016-03-24       Impact factor: 2.447

8.  Peppermint oil solution is useful as an antispasmodic drug for esophagogastroduodenoscopy, especially for elderly patients.

Authors:  Atsushi Imagawa; Hidenori Hata; Morihito Nakatsu; Yasunari Yoshida; Keiko Takeuchi; Toshihiro Inokuchi; Takayuki Imada; Yoshiyasu Kohno; Masahiro Takahara; Kazuyuki Matsumoto; Hirokazu Miyatake; Satoru Yagi; Masaharu Ando; Mamoru Hirohata; Shigeatsu Fujiki; Ryuta Takenaka
Journal:  Dig Dis Sci       Date:  2012-05-06       Impact factor: 3.199

9.  Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation during Endoscopic Submucosal Dissection: A Prospective, Randomized Controlled Study.

Authors:  Ki Joo Kang; Byung-Hoon Min; Mi Jung Lee; Hyun Sook Lim; Jin Yong Kim; Jun Haeng Lee; Dong Kyung Chang; Young-Ho Kim; Poong-Lyul Rhee; Jong Chul Rhee; Jae J Kim
Journal:  Gut Liver       Date:  2011-06-24       Impact factor: 4.519

10.  Glossopharyngeal Nerve Block versus Lidocaine Spray to Improve Tolerance in Upper Gastrointestinal Endoscopy.

Authors:  Moisés Ortega Ramírez; Benigno Linares Segovia; Marco Antonio García Cuevas; Jorge Luis Sánchez Romero; Illich Botello Buenrostro; Norma Amador Licona; Juan Manuel Guízar Mendoza; Jesús Francisco Guerrero Romero; Víctor Manuel Vázquez Zárate
Journal:  Gastroenterol Res Pract       Date:  2013-03-05       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.